Physician profile
Todd H Berinstein
NPI 1508826744
$13,726.15
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,336 · 2020: $874 · 2021: $3,283 · 2022: $1,120 · 2023: $2,770 · 2024: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,046 · Travel and Lodging: $968 · Consulting Fee: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,045.96 |
| Travel and Lodging | $968.03 |
| Consulting Fee | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $4,617.77 | 2019-2021 | |
| Aerin Medical INC. | $2,128.05 | 2019-2024 | |
| Medical Device Business Services, INC. | $1,949.78 | 2021 | |
| Glaxosmithkline, LLC. | $1,357.22 | 2021-2024 | Nucala |
| Intersect Ent, INC. | $801.61 | 2019-2022 | |
| Acclarent, INC | $664.62 | 2019-2024 | Acclarent Aera, Trudi Nav Cable |
| Medtronic, INC. | $559.64 | 2021-2023 | Nuvent, Straightshot |
| Regeneron Healthcare Solutions, INC. | $370.89 | 2019-2024 | Dupixent |
| Genzyme Corporation | $304.88 | 2021-2024 | |
| Alk-Abello, INC | $241.47 | 2019-2020 | |
| Pharming Healthcare, INC. | $148.43 | 2023-2024 | Joenja, Ruconest |
| Kaleo, INC. | $147.76 | 2021-2022 | |
| Med-El Corporation | $143.50 | 2019-2020 | |
| Stryker Corporation | $83.47 | 2019-2021 | |
| Abbvie INC. | $69.98 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $32.98 | 2021 | |
| Smith+Nephew, INC. | $32.22 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $26.39 | 2023 | |
| Livanova USA, INC. | $16.25 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.73 | 2022 | |
| Medtronic USA, INC. | $13.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Berinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.